Although the tumor sites, i.e., the oral cavity, larynx, or hypopharynx, did not show statistical significance in the expression of the PD-L1 marker, a statistically significant association was seen in positive CPS ≥20 with oral cavity tumors showing a high incidence. Here, CD274 is linked to neoplasm.